IBDEI0B2 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4829,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4829,1,4,0)
 ;;=4^787.29
 ;;^UTILITY(U,$J,358.3,4829,1,5,0)
 ;;=5^OTHER DYSPHAGIA
 ;;^UTILITY(U,$J,358.3,4829,2)
 ;;=^335280
 ;;^UTILITY(U,$J,358.3,4830,0)
 ;;=199.1^^23^242^77
 ;;^UTILITY(U,$J,358.3,4830,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4830,1,4,0)
 ;;=4^199.1
 ;;^UTILITY(U,$J,358.3,4830,1,5,0)
 ;;=5^METASTATIC CANCER
 ;;^UTILITY(U,$J,358.3,4830,2)
 ;;=^87705
 ;;^UTILITY(U,$J,358.3,4831,0)
 ;;=338.29^^23^242^33
 ;;^UTILITY(U,$J,358.3,4831,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4831,1,4,0)
 ;;=4^338.29
 ;;^UTILITY(U,$J,358.3,4831,1,5,0)
 ;;=5^CHRONIC PAIN NEC
 ;;^UTILITY(U,$J,358.3,4831,2)
 ;;=^334077
 ;;^UTILITY(U,$J,358.3,4832,0)
 ;;=338.4^^23^242^34
 ;;^UTILITY(U,$J,358.3,4832,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4832,1,4,0)
 ;;=4^338.4
 ;;^UTILITY(U,$J,358.3,4832,1,5,0)
 ;;=5^CHRONIC PAIN SYNDROME
 ;;^UTILITY(U,$J,358.3,4832,2)
 ;;=^334079
 ;;^UTILITY(U,$J,358.3,4833,0)
 ;;=585.1^^23^242^29
 ;;^UTILITY(U,$J,358.3,4833,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4833,1,4,0)
 ;;=4^585.1
 ;;^UTILITY(U,$J,358.3,4833,1,5,0)
 ;;=5^CHRO KIDNEY DIS STAGE I
 ;;^UTILITY(U,$J,358.3,4833,2)
 ;;=^332807
 ;;^UTILITY(U,$J,358.3,4834,0)
 ;;=585.2^^23^242^30
 ;;^UTILITY(U,$J,358.3,4834,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4834,1,4,0)
 ;;=4^585.2
 ;;^UTILITY(U,$J,358.3,4834,1,5,0)
 ;;=5^CHRO KIDNEY DIS STAGE II
 ;;^UTILITY(U,$J,358.3,4834,2)
 ;;=^332808
 ;;^UTILITY(U,$J,358.3,4835,0)
 ;;=585.3^^23^242^27
 ;;^UTILITY(U,$J,358.3,4835,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4835,1,4,0)
 ;;=4^585.3
 ;;^UTILITY(U,$J,358.3,4835,1,5,0)
 ;;=5^CHR KIDNEY DIS STAGE III
 ;;^UTILITY(U,$J,358.3,4835,2)
 ;;=^332809
 ;;^UTILITY(U,$J,358.3,4836,0)
 ;;=585.4^^23^242^28
 ;;^UTILITY(U,$J,358.3,4836,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4836,1,4,0)
 ;;=4^585.4
 ;;^UTILITY(U,$J,358.3,4836,1,5,0)
 ;;=5^CHR KIDNEY DIS STAGE IV
 ;;^UTILITY(U,$J,358.3,4836,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,4837,0)
 ;;=585.5^^23^242^31
 ;;^UTILITY(U,$J,358.3,4837,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4837,1,4,0)
 ;;=4^585.5
 ;;^UTILITY(U,$J,358.3,4837,1,5,0)
 ;;=5^CHRON KIDNEY DIS STAGE V
 ;;^UTILITY(U,$J,358.3,4837,2)
 ;;=^332811
 ;;^UTILITY(U,$J,358.3,4838,0)
 ;;=585.6^^23^242^52
 ;;^UTILITY(U,$J,358.3,4838,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4838,1,4,0)
 ;;=4^585.6
 ;;^UTILITY(U,$J,358.3,4838,1,5,0)
 ;;=5^END STAGE RENAL DISEASE
 ;;^UTILITY(U,$J,358.3,4838,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,4839,0)
 ;;=585.9^^23^242^32
 ;;^UTILITY(U,$J,358.3,4839,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4839,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,4839,1,5,0)
 ;;=5^CHRONIC KIDNEY DIS NOS
 ;;^UTILITY(U,$J,358.3,4839,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,4840,0)
 ;;=599.70^^23^242^60
 ;;^UTILITY(U,$J,358.3,4840,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4840,1,4,0)
 ;;=4^599.70
 ;;^UTILITY(U,$J,358.3,4840,1,5,0)
 ;;=5^HEMATURIA NOS
 ;;^UTILITY(U,$J,358.3,4840,2)
 ;;=^336751
 ;;^UTILITY(U,$J,358.3,4841,0)
 ;;=784.59^^23^242^48
 ;;^UTILITY(U,$J,358.3,4841,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4841,1,4,0)
 ;;=4^784.59
 ;;^UTILITY(U,$J,358.3,4841,1,5,0)
 ;;=5^DYSPHASIA
 ;;^UTILITY(U,$J,358.3,4841,2)
 ;;=^338287
 ;;^UTILITY(U,$J,358.3,4842,0)
 ;;=787.60^^23^242^70
 ;;^UTILITY(U,$J,358.3,4842,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4842,1,4,0)
 ;;=4^787.60
 ;;^UTILITY(U,$J,358.3,4842,1,5,0)
 ;;=5^INCONTINENCE OF FECES
 ;;^UTILITY(U,$J,358.3,4842,2)
 ;;=^339670
 ;;^UTILITY(U,$J,358.3,4843,0)
 ;;=309.0^^23^243^3
 ;;^UTILITY(U,$J,358.3,4843,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0B2
